: Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Novo Nordisk’s new drug IDegLira is a fixed-ratio combination of insulin degludec and the glucagonlike perptide-1 (GLP-1) agonist liraglutide. It combines the effects of insulin degludec and liraglutide in a once daily injection.
Read more
More Information on a Novel Insulin/GLP-1 Combo
Posted in Drugs Glucose & Insulin